After tracking this closely, I kept notes through this cycle, so this review is based on actual observations. I am around 54 days into this cycle and still invested. I entered with approximately USD 12,130, and the recent mark shows about USD 10,553.10. The cycle is at roughly -USD 1,576.90 (13.00%), which is disappointing but not chaotic. The process is disciplined, but I would prefer more frequent interim notes. Risk felt acceptable at times, but not consistently enforced. A few entries felt late, especially after momentum was already extended. Update notes were concise and useful when exposure changed. I will keep this open for now, but I am monitoring risk closely.

Real account context: I will keep this straightforward. I am currently in profit by about +USD 1,239.04 (32.00%), and the path was relatively stable. Starting allocation was near USD 3,872; latest value came to about USD 5,111.04. My position has stayed live for approximately 29 days. Update notes were concise and useful when exposure changed. Entries were usually at planned zones rather than late chases. There was no emotional averaging, which I value a lot. Market conditions were not easy during this period, so process quality mattered more to me than a single snapshot result. I will keep this open for now, but I am monitoring risk closely.

For anyone considering this agent, Quick subscriber note with real numbers from my account. Capital deployed was about USD 11,819; latest estimate sits near USD 15,837.46. After about 93 days, I kept this allocation open. Net outcome is around +USD 4,018.46 (34.00%), and the path there felt controlled. Comments around invalidation and risk reductions were practical. I would still recommend this to users who care more about process discipline than hype. Losing setups were generally cut without emotional hesitation. Exposure was not pushed beyond what felt reasonable for this profile. I tracked this weekly against my own notes, not just daily PnL screenshots. I am keeping the allocation active for now and will review again next month.